Mountain View, CA, United States of America

Camellia W Adams

This inventor holds 25 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camellia W Adams. Retrieved from https://idiyas.com/inventor/camellia-w-adams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 5)

% Patents Active = 72.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 3.7

ph-index = 11

Forward Citations = 729(Granted Patents)

Location History:

San Jose, CA (US) (2009 - 2013)
Mountain View, CA (US) (2002 - 2014)

Company Filing History:

Years Active: 2002-2014

Loading Chart...

Areas of Expertise:

Antibody Variants

Lymphotoxin

Immunoglobulin

Apoptosis Induction

Humanized Antibodies

Apo-2 Receptor

Cancer Treatment

ErbB2

TGF-beta

Thrombotic Disorders

Agonist Antibodies

Nucleic Acid Encoding

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8642740 - Antibodies to lymphotoxin-alpha (2014-02-04),

2. 8562992 - Immunoglobulin variants and uses thereof (2013-10-22),

3. 8541552 - Antibodies to lymphotoxin-α (2013-09-24),

4. 8409570 - Method of inducing apoptosis using anti-DR5 antibodies (2013-04-02),

5. 8216807 - Antibodies to lymphotoxin-α (2012-07-10),

6. 8092799 - Antibodies to Apo-2 receptor polypeptides (2012-01-10),

7. 8030023 - Nucleic acid encoding DR5 antibodies and uses thereof (2011-10-04),

8. 8029783 - DR5 antibodies and articles of manufacture containing same (2011-10-04),

9. 8012482 - Humanized anti-TGF-beta antibodies (2011-09-06),

10. 7923011 - Antibodies to lymphotoxin-alpha (2011-04-12),

11. 7862817 - Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies (2011-01-04),

12. 7807153 - Apo-2 receptor agonist antibodies (2010-10-05),

13. 7799900 - Immunoglobulin variants and uses thereof (2010-09-21),

14. 7595046 - Treatment of cancer using anti-Apo-2 antibodies (2009-09-29),

15. 7537931 - Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies (2009-05-26),

Title: The Innovative Journey of Camellia W Adams

Introduction: Camellia W Adams, a pioneering inventor based in Mountain View, CA, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Camellia W Adams holds several patents in various fields, including technology, healthcare, and sustainability. His recent patents focus on renewable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Camellia W Adams has established himself as a visionary inventor. He has worked with leading research institutions and companies to bring his ideas to life, revolutionizing industries along the way.

Collaborations: Throughout his career, Camellia W Adams has collaborated with top engineers, scientists, and designers to create cutting-edge products. His collaborative spirit and innovative mindset have led to the development of groundbreaking technologies.

Conclusion: Camellia W Adams continues to push the boundaries of innovation, inspiring the next generation of inventors to think outside the box and create a better future for all. His passion for creating solutions to complex problems makes him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.